Renier van der Westhuyzen

Author

Also Known As

Moolman, Wessel J.A., Renier Van der Westhuyzen, Renier van der Westhuyzen, Renier van der Westhuyzen, van der Westhuyzen, Renier

Publications

336

Citations

H-Index

Concepts

All Affiliations

University of Cape Town South African Medical Research Council Stellenbosch University University of California San Diego Novartis (Singapore)

About

Renier van der Westhuyzen is an author at University of Cape Town specializing in medicine, biochemistry, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	264
2	Biochemistry	5	5	247
3	Natural Sciences	4	4	204
4	Chemical Biology	2	2	58
5	Health Sciences	1	1	43

Renier van der Westhuyzen

Publications

329

Citations

H-Index

Page 1

	Year	Citations
Pyrrolo[3,4-<i>c</i>]pyridine-1,3(2<i>H</i>)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial Respiration Renier van der Westhuyzen, Susan Winks, Colin R. Wilson, Journal of Medicinal Chemistry Antimicrobial ChemotherapyPharmaceutical ChemistryDrug ResistanceM. TuberculosisMycobacterium Tuberculosis	2015	83
Defining the Determinants of Specificity of <i>Plasmodium</i> Proteasome Inhibitors Euna Yoo, Barbara H. Stokes, Hanna de Jong, Journal of the American Chemical Society Magnitude SelectivityDrug TargetBiochemistryAntiparasitic AgentMedicine	2018	63
Michael Acceptor-Containing Coenzyme A Analogues As Inhibitors of the Atypical Coenzyme A Disulfide Reductase from <i>Staphylococcus aureus</i> Renier van der Westhuyzen, Erick Strauss Journal of the American Chemical Society	2010	47
Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization Candice Soares de Melo, Tzu‐Shean Feng, Renier van der Westhuyzen, Bioorganic & Medicinal Chemistry Pulmonary TuberculosisBiochemistryMedicineNatural SciencesMycobacterium Tuberculosis	2015	46
The Antibiotic CJ-15,801 Is an Antimetabolite that Hijacks and Then Inhibits CoA Biosynthesis Renier van der Westhuyzen, Justin C. Hammons, Jordan L. Meier, Chemistry & Biology Antimicrobial Drug DiscoveryBiosynthesisHealth SciencesAntibioticsBiochemistry	2012	43
Benzoheterocyclic Oxime Carbamates Active against <i>Mycobacterium tuberculosis</i>: Synthesis, Structure–Activity Relationship, Metabolism, and Biology Triaging Renier van der Westhuyzen, Amanda Mabhula, Paul M. Njaria, Journal of Medicinal Chemistry	2021	18
Potentiation of rifampin activity in a mouse model of tuberculosis by activation of host transcription factor EB Ruslana Bryk, Shashirekha Mundhra, Xiuju Jiang, PLoS Pathogens Rifampin ActivityMicrobial PathogensAdaptive Immune SystemInnate Immune SystemImmunology	2020	17
Turnover-Dependent Covalent Inactivation of <i>Staphylococcus aureus</i> Coenzyme A-Disulfide Reductase by Coenzyme A-Mimetics: Mechanistic and Structural Insights Bret D. Wallace, Jonathan S. Edwards, Jamie R. Wallen, Biochemistry Aldo-keto ReductaseMolecular BiologyEnzyme DimerAnalytical UltracentrifugationChemical Biology	2012	12

Page 1